FDA clears Luminex MRSA assay

Create PDF

December 2019—Luminex Corp. has received FDA 510(k) clearance for the Aries MRSA Assay. The assay is an integrated, real-time polymerase chain reaction–based, qualitative, in vitro diagnostic test for the direct detection of methicillin-resistant Staphylococcus aureus DNA from nasal swabs in patients at risk for nasal colonization.